Quantitative Analysis of Twelve Marker Compounds in Palmijihwang-hwan using Ultra-Performance Liquid Chromatography Coupled with Electrospray Ionization Tandem Mass Spectrometry

  • Seo, Chang-Seob (Herbal Medicine Formulation Research Group, Korea Institute of Oriental Medicine) ;
  • Shin, Hyeun-Kyoo (Herbal Medicine Formulation Research Group, Korea Institute of Oriental Medicine)
  • Received : 2014.04.28
  • Accepted : 2014.05.29
  • Published : 2014.09.30

Abstract

An ultra-performance liquid chromatography (UPLC) coupled with electrospray ionization (ESI) tandem mass spectrometry (MS) method was established for quantitative analysis of twelve components, allantoin (1), morroniside (2), 5-hydroxymethyl-2-furfural (5-HMF) (3), loganin (4), coumarin (5), cinnamic acid (6), mesaconitine (7), cinnamaldehyde (8), hypaconitine (9), aconitine (10), alisol B (11), and alisol B acetate (12) in a Palmijihwang-hwan decoction. The twelve constituents were separated on a UPLC BEH C18 column ($2.1{\times}100mm$, $1.7{\mu}m$) at a column temperature of $40^{\circ}C$ by gradient elution with 0.1% (v/v) formic acid in water and acetonitrile as the mobile phase. The flow rate was 0.3 mL/min and the injection volume was $2.0{\mu}L$. Calibration curves of all compounds were acquired with values of the correlation coefficient ${\geq}0.99$ within the test ranges. The limits of detection and quantification for all analytes were 0.01 - 4.53 ng/mL and 0.03 - 13.60 ng/mL, respectively. The concentrations of the compounds 1 - 9 and 12 were 72.83, 4389.00, 4859.00, 3155.17, 223.67, 33.50, 1.97, 518.00, 2.25, and $25.00{\mu}g/g$, respectively. However, compounds 10 and 11 were not detected.

Keywords

References

  1. Qiu, J. Nat. Rev. Drug Discov. 2007, 6, 506-507. https://doi.org/10.1038/nrd2350
  2. Wang, L.; Zhou, G. B.; Liu, P.; Song, J. H.; Liang, Y.; Yan, X. J.; Xu, F.; Wang, B. S.; Mao, J. H.; Shen, Z. X.; Chen, S. J.; Chen, Z. Proc. of the Natl. Acad. Sci. U. S. A. 2008, 105, 4826-4831. https://doi.org/10.1073/pnas.0712365105
  3. Chen, H.; Wu, M.; Kubo, K. J. Ethnopharmacol. 2012, 142, 80-85. https://doi.org/10.1016/j.jep.2012.04.017
  4. Ikeda, R.; Mizoguchi, K. J. Ethnopharmacol. 2009, 124, 176-181. https://doi.org/10.1016/j.jep.2009.04.044
  5. Yamabe, N.; Yokozawa, T. J. Ethnopharmacol. 2007, 113, 91-99. https://doi.org/10.1016/j.jep.2007.05.010
  6. Oka, H.; Goto, H.; Koizumi, K.; Nakamura, S.; Tsuneyama, K.; Zhou, Y.; Jo, M.; Fujimoto, T.; Sakurai, H.; Shibahara, N.; Saiki, I.; Shimada, Y. Evid. Based Complement. Alternat. Med. 2011, doi:10.1155/2011/348686.
  7. Turner, R.; Stamp, L. K.; Kettle, A. J. J. Chromatogr. B 2012, 891-892, 85-89. https://doi.org/10.1016/j.jchromb.2012.02.009
  8. Liu, Z.; Zhu, Z.; Zhang, H.; Tan, G.; Chen, X.; Chai, Y. J. Pharm. Biomed. Anal. 2011, 55, 557-562. https://doi.org/10.1016/j.jpba.2011.02.007
  9. Ye, J.; Zhang, X.; Dai, W.; Tan, S.; Huang, H.; Liang, X.; Li, Y.; Zhang, W. J. Pharm. Biomed. Anal. 2009, 49, 638-645. https://doi.org/10.1016/j.jpba.2008.12.009
  10. Gardana, C.; Scaglianti, M.; Pietta, P.; Simonetti, P. J. Pharm. Biomed. Anal. 2007, 45, 390-399. https://doi.org/10.1016/j.jpba.2007.06.022
  11. Flamini, R.; Vedova, A. D.; Cancian, D.; Panighel, A.; De Rosso, M. J. Mass Spcetrom. 2007, 42, 641-646. https://doi.org/10.1002/jms.1193
  12. Concannon, S.; Ramachandran, V. N.; Smyth, W. F. Rapid Commun. Mass Spectrm. 2000, 14, 1157-1166. https://doi.org/10.1002/1097-0231(20000730)14:14<1157::AID-RCM4>3.0.CO;2-V
  13. Yan, G.; Sun, H.; Sun, W.; Zhao, L.; Meng, X.; Wang, X. J. Pharm. Biomed. Anal. 2010, 53, 421-431. https://doi.org/10.1016/j.jpba.2010.05.004
  14. Chen, L.; Qi, J.; Chang, Y.; Zhu, D.; Yu, B. J. Pharm. Biomed. Anal. 2009, 50, 127-137. https://doi.org/10.1016/j.jpba.2009.03.039
  15. Liu, X.; Li, S. L.; Zhou, Y.; Song, J. Z.; Zheng, Y. F.; Peng, G. P.; Xu, H. X. Rapid Commun. Mass Spectrom. 2010, 24, 1514-1522. https://doi.org/10.1002/rcm.4548